Jacobs & Co
TMO icon

Jacobs & Co’s Thermo Fisher Scientific TMO Stock Holding History

Jacobs & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4M Sell
15,386
-790
-5% -$469K 0.9% 37
2026
Q2 		$8.11M Sell
16,176
-1,072
-6% -$515K 0.7% 53
2026
Q1 		$8.48M Buy
17,248
+13
+0.1% +$7.06K 0.84% 47
2025
Q4 		$10M Sell
17,235
-493
-3% -$279K 0.94% 42
2025
Q3 		$8.6M Buy
17,728
+221
+1% +$103K 0.82% 52
2025
Q2 		$7.1M Buy
17,507
+2,090
+14% +$874K 0.7% 59
2025
Q1 		$7.67M Buy
15,417
+211
+1% +$114K 0.82% 51
2024
Q4 		$7.91M Buy
15,206
+1,473
+11% +$810K 0.8% 51
2024
Q3 		$8.49M Sell
13,733
-161
-1% -$95.3K 0.85% 49
2024
Q2 		$7.68M Sell
13,894
-194
-1% -$111K 0.81% 51
2024
Q1 		$8.19M Sell
14,088
-78
-0.6% -$43.8K 0.87% 49
2023
Q4 		$7.52M Buy
14,166
+2,460
+21% +$1.19M 0.85% 51
2023
Q3 		$5.92M Buy
11,706
+4,977
+74% +$2.65M 0.74% 56
2023
Q2 		$3.51M Buy
6,729
+6,017
+845% +$3.25M 0.42% 74
2023
Q1 		$410K Hold
712
– – 0.05% 100
2022
Q4 		$392K Sell
712
-25
-3% -$13.2K 0.05% 102
2022
Q3 		$373K Hold
737
– – 0.05% 99
2022
Q2 		$400K Hold
737
– – 0.05% 95
2022
Q1 		$435K Hold
737
– – 0.05% 97
2021
Q4 		$491K Hold
737
– – 0.05% 97
2021
Q3 		$421K Hold
737
– – 0.05% 98
2021
Q2 		$371K Hold
737
– – 0.04% 99
2021
Q1 		$336K Sell
737
-50
-6% -$23.9K 0.04% 100
2020
Q4 		$366K Buy
787
+50
+7% +$23.4K 0.05% 96
2020
Q3 		$325K Hold
737
– – 0.05% 96
2020
Q2 		$267K Hold
737
– – 0.04% 101
2020
Q1 		$209K Hold
737
– – 0.04% 120
2019
Q4 		$239K Sell
737
-13
-2% -$3.94K 0.04% 121
2019
Q3 		$218K Hold
750
– – 0.04% 130
2019
Q2 		$220K Hold
750
– – 0.04% 134
2019
Q1 		$205K Buy
+750
New +$187K 0.03% 131

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Jacobs & Co's TMO Position: Q3 2026 in Review

Jacobs & Co reduced its Thermo Fisher Scientific (TMO) stake by 4.9% in Q3 2026, selling an estimated $469K and leaving 15,386 shares worth $10.4M. The position accounts for 0.9% of the portfolio, ranked #37.

Jacobs & Co first reported a position in TMO in Q1 2019 and has held it in 31 quarters since. 1,167 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Jacobs & Co held 15,386 shares of Thermo Fisher Scientific worth $10.4M as of Q3 2026.
  • Jacobs & Co sold 790 Thermo Fisher Scientific shares in Q3 2026, an estimated $469K.
  • Thermo Fisher Scientific made up 0.9% of Jacobs & Co's portfolio in Q3 2026, its #37 holding.
  • Jacobs & Co first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 31 quarters since.
  • 1,167 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Jacobs & Co's 13F filing for Q3 2026, filed 9 Oct 2026.